Skip to main content

Articles

Page 8 of 8

  1. Significant precipitation produced by the dilution of diazepam (DZP) injection with an infusion fluid is a great concern for the clinical practice. In this study, the precipitation behavior under different con...

    Authors: Yoshinori Onuki, Naoki Hasegawa, Chihiro Kida, Mayumi Ikegami-Kawai, Masayoshi Tsubuki, Shunsuke Shirozu, Yasuko Obata and Kozo Takayama
    Citation: Journal of Pharmaceutical Health Care and Sciences 2015 1:9
    Content type: Research article Published on:

  2. It is important for pharmacists to manage cancer chemotherapy regimens in order to achieve safe treatment. We examined whether there was a useful pharmacoeconomic benefit of compliance the exclusion criteria o...

    Authors: Makoto Hayashi, Akimasa Yamatani, Hiromu Funaki and Kenichi Miyamoto
    Citation: Journal of Pharmaceutical Health Care and Sciences 2015 1:10
    Content type: Research article Published on:

    The Erratum to this article has been published in Journal of Pharmaceutical Health Care and Sciences 2016 2:3

  3. Crizotinib, an ATP-competitive receptor tyrosine kinase inhibitor of both anaplastic lymphoma kinase (ALK) and the hepatocyte growth factor receptor, commonly causes several adverse events (AEs). The clinical ...

    Authors: Yasuko Kurata, Narumi Miyauchi, Manabu Suno, Takahiro Ito, Toshiaki Sendo and Katsuyuki Kiura
    Citation: Journal of Pharmaceutical Health Care and Sciences 2015 1:8
    Content type: Short report Published on:

  4. It is well known that molecular-targeted drugs, of which sorafenib (Nexavar®) is one, differ from previous anticancer drugs and cause various unusual adverse drug reactions. Treatment with sorafenib causes adv...

    Authors: Makoto Kajizono, Megumu Aoyagi, Yoshihisa Kitamura and Toshiaki Sendo
    Citation: Journal of Pharmaceutical Health Care and Sciences 2015 1:6
    Content type: Research article Published on:

  5. The lower urinary tract symptoms (LUTS) increases with age and can have a significant effect on the quality of life of the patients. Elderly patients, who are often characterized by a decline in physiological ...

    Authors: Masako Hashimoto, Kanako Hashimoto, Fumihiko Ando, Yoshiaki Kimura, Keisuke Nagase and Kunizo Arai
    Citation: Journal of Pharmaceutical Health Care and Sciences 2015 1:7
    Content type: Research article Published on:

  6. Tramadol ((±)-TRA) is recommended for the treatment of mild to moderate cancer pain by the World Health Organization. An oral liquid formulation of (±)-TRA is preferable for patients with a compromised swallow...

    Authors: Manabu Suno, Hidenori Ichihara, Takahiro Ishino, Kento Yamamoto and Yuta Yoshizaki
    Citation: Journal of Pharmaceutical Health Care and Sciences 2015 1:5
    Content type: Research article Published on:

  7. Delirium is an acute change in cognition and concentration that complicates the postoperative course. Patients who suffer delirium after surgery have an increased risk of persistent cognitive impairment, funct...

    Authors: Kiminaka Murakawa, Yoshihisa Kitamura, Saori Watanabe, Shiho Hongo, Kazuaki Shinomiya and Toshiaki Sendo
    Citation: Journal of Pharmaceutical Health Care and Sciences 2015 1:4
    Content type: Research article Published on:

  8. In the construction of pharmacoeoconomic models, simplicity is desirable for transparency (people can see how the model is built), ease of analysis, validation (how well the model reproduces reality), and desc...

    Authors: Takeshi Uchikura, Makoto Kobayashi, Masayuki Hashiguchi and Mayumi Mochizuki
    Citation: Journal of Pharmaceutical Health Care and Sciences 2015 1:3
    Content type: Research article Published on:

  9. To improve the adherence to and knowledge about pharmacotherapy in outpatients and to maximize the efficacy and minimize the adverse drug events, the first pharmacist-managed clinic (PMC) in Japan was establis...

    Authors: Kiyofumi Yamada and Toshitaka Nabeshima
    Citation: Journal of Pharmaceutical Health Care and Sciences 2015 1:2
    Content type: Review Published on:
JSPHCS

Official journal of JSPHCS

Submit manuscript

Annual Journal Metrics

  • Citation Impact 2023
    Journal Impact Factor: 1.2
    5-year Journal Impact Factor: 1.4
    Source Normalized Impact per Paper (SNIP): 0.557
    SCImago Journal Rank (SJR): 0.312

    Speed 2023
    Submission to first editorial decision (median days): 7
    Submission to acceptance (median days): 88

    Usage 2023
    Downloads: 407,928
    Altmetric mentions: 83

Journal of Pharmaceutical Health Care and Sciences

ISSN: 2055-0294

Contact us